InsideArbitrage Event Driven Monitor – April 8, 2026

Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage SLNO: Soleno (SLNO) announced that it had voluntarily withdrawn its marketing authorization application (MAA) for VIOKAT prolonged-release tablets (diazoxide choline), which is marketed in the United States as VYKATTM XR, its medicinal product for the treatment of